Navigation Links
Aware, Inc. Reports First Quarter 2013 Financial Results

BEDFORD, Mass., April 23, 2013 /PRNewswire/ -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software and services and DSL service assurance software products, today reported financial results for its first quarter ended March 31, 2013. 

Revenue for the first quarter of 2013 was $5.6 million, an increase of 15% compared to $4.9 million in the same quarter last year. Operating income before patent related income in the first quarter of 2013 was $2.0 million compared to $1.0 million in the first quarter of 2012.

Net income for the first quarter of 2013 was $1.9 million, or $0.08 per diluted share, which compares to net income of $1.1 million, or $0.05 per diluted share, for the same period a year ago.

Additional information regarding first quarter 2013 results is as follows:

  • The improvement in operating income before patent related income this year versus last year was primarily due to increased profitability in our biometrics and imaging business and lower general and administrative expenses.
  • Net income in the first quarter of 2013 included income from a patent arrangement of $0.8 million. This income relates to an agreement we entered into several years ago with an unaffiliated third party under which we assigned patents in return for royalties on proceeds from its patent monetization efforts. We are unable to predict how much more income we might receive from this arrangement, if any, because we do not know whether any patent monetization efforts by the third party will be successful.
  • Income tax expense for the first quarter of 2013 was $1.0 million versus $2,000 in the prior year quarter.
    Income tax expense this year was based on the U.S. statutory rate of 34%, increased by state income taxes.  Income tax expense in the first quarter of 2012 was offset by the reversal of the valuation allowance on deferred tax assets, which reduced our tax expense to zero, except for $2,000 of state excise taxes.
  • Rick Moberg , Aware's co-chief executive officer and chief financial officer, said, "Our strong operating results this quarter were driven by record revenue and profitability in our biometrics and imaging business. Biometrics revenue growth was primarily the result of a large sale to a government agency, solid international sales, and sales of licenses to OEM customers. G&A expenses benefitted from lower patent related expenses as a result of our 2012 patent sales."

    About Aware
    Aware is a leading software and technology supplier for the biometrics, telecommunications, and healthcare industries. Aware's biometrics software products and services are provided to solution vendors and system integrators for use by government agencies towards applications including border management, secure credentials, law enforcement, and national defense. Aware's DSL Service Assurance Group offers test and diagnostics software products that enable broadband service providers to manage their DSL networks. Aware also provides standards-based medical imaging software products to the healthcare industry.  Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts.

    Safe Harbor Warning
    Portions of this release contain forward-looking statements regarding future events and are subject to risks and uncertainties, such as estimates or projections of future revenue and earnings, and the growth of the DSL service assurance and biometrics markets. Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements.

    General factors include, but are not limited to: our quarterly results are unpredictable and may fluctuate significantly; our business is subject to rapid technological change; we face intense competition from a wide range of competitors; our intellectual property is subject to limited protection; our business may be affected by our use of open source software; our business may be affected by government regulations; adverse economic conditions; and our ability to obtain or enforce patents could be affected by new laws, regulations or rules. DSL service assurance factors include, but are not limited to: our DSL service assurance product line depends upon a limited number of customers; our DSL service assurance software products face intense competition; and our DSL service assurance software products could have quality problems. Biometric factors include, but are not limited to: market acceptance of our biometric technologies and products; changes in contracting practices of government or law enforcement agencies; the failure of the biometrics market to experience continued growth; announcements or introductions of new technologies or products by our competitors; failures or problems in our biometric software products; delays in the adoption of new industry biometric standards; growth of proprietary biometric systems which do not conform to industry standards; our ability to sell services contracts in a manner that is consistent with our business model; our ability to deliver services contract milestones; and our dependence on third party contractors and consultants to deliver certain services contract milestones.

    We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2012 and other reports and filings made with the Securities and Exchange Commission.

    Aware is a trademark or registered trademark of Aware, Inc.
    Any other trademarks appearing herein are the property of their respective owners.
    AWARE, INC.CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)(unaudited)Three Months Ended
    March 31,20132012Revenue:Software licenses$3,808$2,839Software maintenance1,041881Services476693Royalties291491  Total revenue5,6164,904Costs and expenses:Cost of services221356Research and development1,5571,436Selling and marketing1,0951,079General and administrative731985  Total costs and expenses3,6043,856Operating income before patent related income2,0121,048Income from patent arrangement780-Operating income after patent related income2,7921,048Other income-26Interest income8252Income from continuing operations before income taxes2,8741,126Provision for income taxes1,0172Income from continuing operations1,8571,124Loss from discontinued operations, net of income taxes-(6)Net income$1,857$1,118Basic net income per share:Basic net income per share from continuing operations$0.08$0.05Basic net loss per share from discontinued operations0.00(0.00)Basic net income per share$0.08$0.05Diluted net income per share:Diluted net income per share from continuing operations$0.08$0.05Diluted net loss per share from discontinued operations 0.00(0.00)Diluted net income per share$0.08$0.05Weighted-average shares – basic22,51120,724Weighted-average shares - diluted22,56420,928AWARE, INCCONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(unaudited)March 31,2013December 31,2012 

    ASSETSCash and investments$74,570$73,084Accounts receivable, net5,8294,578Property and equipment, net5,8675,904Deferred tax assets1,6101,760Other assets, net568528Total assets$88,444$85,854LIABILITIES AND STOCKHOLDERS' EQUITYTotal current liabilities$3,480$3,639Long-term deferred revenue285319Total stockholders' equity84,67981,896Total liabilities and stockholders' equity$88,444$85,854 

    SOURCE Aware, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related biology news :

    1. NASDAQ Sets Ex-Dividend Date for Aware, Inc.s Special Cash Dividend of $1.80 Per Share
    2. Aware, Inc. Declares Special Cash Dividend of $1.80 Per Share, or Approximately $40 Million in Total
    3. Aware, Inc. Reports Third Quarter 2012 Financial Results
    4. Aware, Inc. Reports Second Quarter 2012 Financial Results
    5. Aware, Inc. Reports First Quarter 2012 Financial Results
    6. University of Florida reports 2012 US shark attacks highest since 2000
    7. Invading species can extinguish native plants despite recent reports
    8. Study reports iron oxide nanoparticles effective for labeling human endothelial cells
    9. Cell Transplantation reports islet cell advancement increases impact on transplantation
    10. New low carbon TINA reports
    11. Texas Biomed reports faster, more economical method for detecting bioterror threats
    Post Your Comments:
    (Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis zum Jahr 2018 ... mehr als 50 Vertretern aus verschiedenen Branchen wurde aber klar, ... Prognose zu realisieren. ... Zu den Schwierigkeiten für Biobanking-Profis ... die Biobank, die Implementierung Zeit sparender Technologien, ein besseres ...
    (Date:2/14/2017)... 14, 2017  Wake Forest Baptist Medical Center today ... chief executive officer (CEO). Freischlag joins the medical center ... McConnell , M.D., who last year announced that he ... Center, after leading it since 2008.   ... Wake Forest Baptist,s academic health system, which includes Wake ...
    (Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
    Breaking Biology News(10 mins):
    (Date:2/22/2017)... ... February 22, 2017 , ... ... engineers, and scientists from around the world, is pleased to announce the 2nd ... and 23, 2017. This premier, online-only conference focused on the development and advancements ...
    (Date:2/22/2017)... , Feb. 22, 2017 Aethlon Medical, ... results of a study that validated the ability of ... are associated with increased mortality in immune-suppressed sepsis patients ... The objective of the study was ... Cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Herpes Simplex virus ...
    (Date:2/22/2017)... Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 ... ) today announced its financial results for the ... "Our annual 2016 financial results reflect continued ... earnings exceeded $700 million," said Martine Rothblatt, Ph.D., ... financial results strengthen our ability to develop and ...
    (Date:2/21/2017)... ... February 21, 2017 , ... Vortex Biosciences ... fully automated benchtop system for collecting intact circulating tumor cells (CTCs) that are ... Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 San Francisco). , ...
    Breaking Biology Technology: